Articles published by Anika Therapeutics Inc.
Anika To Participate in December 2024 Investor Conferences
November 22, 2024
Via GlobeNewswire
Tickers
ANIK
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
October 31, 2024
Via GlobeNewswire
Tickers
ANIK
Anika Announces Third Quarter 2024 Results Conference Call Date
October 17, 2024
Via GlobeNewswire
Tickers
ANIK
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024
Via GlobeNewswire
Tickers
ANIK
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 09, 2024
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Anika to Participate in the Sidoti Virtual Investor Conference
August 05, 2024
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
February 27, 2024
Via GlobeNewswire
Tickers
ANIK
Anika to Participate in Upcoming Investor Conferences
November 07, 2023
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 15, 2023
Via GlobeNewswire
Tickers
ANIK
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
September 12, 2023
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Via GlobeNewswire
Tickers
ANIK
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free